Xinzhao Zuo
Overview
Explore the profile of Xinzhao Zuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo X, Wei Q, Jiang X, Chen N, Zuo X, Zhao H, et al.
Cell Death Dis
. 2024 Jun;
15(6):432.
PMID: 38898019
Platinum-based chemotherapy is the standard postoperative adjuvant treatment for ovarian cancer (OC). Despite the initial response to chemotherapy, 85% of advanced OC patients will have recurrent disease. Relapsed disease and...
2.
Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet Y, et al.
Exp Mol Med
. 2024 Feb;
56(3):600-615.
PMID: 38424195
5-Methylcytosine (mC) is a common RNA modification that modulates gene expression at the posttranscriptional level, but the crosstalk between mC RNA modification and biomolecule condensation, as well as transcription factor-mediated...
3.
Chen Y, Zuo X, Wei Q, Xu J, Liu X, Liu S, et al.
Int J Biol Sci
. 2023 Jan;
19(2):691-704.
PMID: 36632452
Cervical cancer (CC) is one of the most common gynecological malignancies with poor prognosis for advanced CC patients. LRRC8A is a volume-regulated anion channel protein involved in cellular homeostasis, but...
4.
Li M, Tang Y, Zuo X, Meng S, Yi P
Bioengineered
. 2021 Dec;
13(1):721-734.
PMID: 34967276
Ovarian cancer (OC) is one of the most lethal gynecological malignancies. However, the molecular mechanisms underlying the development of OC remain unclear. Here, we report that loss of Ras GTPase-activating...